Davenport & Co’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Davenport & Co's EW Position: Q3 2026 in Review
Davenport & Co increased its Edwards Lifesciences (EW) stake by 22% in Q3 2026, buying an estimated $78K and bringing the position to 4,866 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #1069.
Davenport & Co first reported a position in EW in Q2 2018 and has held it in 25 quarters since. The position peaked at $913K in Q4 2021. 1,244 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Davenport & Co held 4,866 shares of Edwards Lifesciences worth $420K as of Q3 2026.
- Davenport & Co bought 878 Edwards Lifesciences shares in Q3 2026, an estimated $78K.
- Edwards Lifesciences made up ﹤0.01% of Davenport & Co's portfolio in Q3 2026, its #1069 holding.
- Davenport & Co first reported a position in Edwards Lifesciences in Q2 2018 and has held it in 25 quarters since.
- Davenport & Co's Edwards Lifesciences position peaked at $913K in Q4 2021.
- 1,244 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Davenport & Co's 13F filing for Q3 2026, filed 14 Oct 2026.